Predictors of future falls in Parkinson disease.
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.1212/wnl.0b013e3181e7b688
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology. 2010;75:116–124. DOI 10.1212/WNL.0b013e3181e7b688
Kerr G, Worringham C, Cole M, Lacherez P, Wood J, Silburn P. Predictors of future falls in Parkinson disease. Neurology. 2010;75(2):116-124. DOI 10.1212/wnl.0b013e3181e7b688
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — balance
- access status: abstract_or_metadata_only
Balance P123/P157: original abstract confirmsN101,optimal medication,6months,48%anyfall24%recurrent, five predictors UPDRS/freezing/orthostasis/Tinetti/APsway with sensitivity78%/specificity84%. Source locator: Official EuropePMC indexed original abstract, archived source evidence Limit: Standalone66/68,LOO72/76,17/59 subgroup69/72,calendar schedule,firmEO protocol and no-calibration/fulltext-inspection assertions not independently checked. QUTPDF403/ACU inaccessible;wrongUFMS article rejected.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — balance1
- access status: abstract_or_metadata_only
Balance P123/P157: original abstract confirmsN101,optimal medication,6months,48%anyfall24%recurrent, five predictors UPDRS/freezing/orthostasis/Tinetti/APsway with sensitivity78%/specificity84%. Source locator: Official EuropePMC indexed original abstract, archived source evidence Limit: Standalone66/68,LOO72/76,17/59 subgroup69/72,calendar schedule,firmEO protocol and no-calibration/fulltext-inspection assertions not independently checked. QUTPDF403/ACU inaccessible;wrongUFMS article rejected.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — strength
- access status: primary_abstract_or_excerpt_only
STR-10-01
Limitations: Only current scoped checks; archived captures not authenticated against live originals.
Parkinson’s disease strength
- current access: primary_abstract_or_excerpt_only
- primary version: Primary abstract or excerpt
Parkinson’s disease strength component — Kerr abstract-verifiable design/model only
The abstract verifies 101 early-stage PD participants, six-month follow-up, 48%/24% fall/recurrent proportions, the selected five-factor model and apparent 78%/84% accuracy. Exact strength tables and entry criterion remain unavailable.
Source locator: Primary abstract
Limitations: Exact 48/24 counts, force 27.4/33.0, p.045, entryp<.01, leave-one-out 72/76 andattrition requireauthorbody. AI-assisted source comparison; no raw-data verification.
Reports citing this source
- Standing balance assessment and prognosis in Parkinson’s disease · reference 7 · original reference
- Standing balance assessment and prognosis in Parkinson’s disease · reference 6 · original reference
- Strength muscle power and rapid force production assessment in Parkinson’s disease · reference 10 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide